Centers for Disease Control and Prevention (CDC)

Collaboration Title	Collaboration Type	HHS Participating Agencies	NIH Participating Institutes/ Centers/ Office of the Director	Year Collaboration Originated
Canadian - U.S. Dietary Reference Intakes Working Group	Committee, Advisory Group, or Work Group	AHRQ, CDC, FDA, OASH	NIDDK, OD/ DPCPSI/ ODS	2005
CDC Acute Flaccid Myelitis Task Force	Committee, Advisory Group, or Work Group	CDC	NIAID, NINDS	2018
CDC Integration with GrantSolutions	Resource Development	ACF, CDC	OD/ OER	2016
CDC Office of Public Health Genomics	Public Education Campaign	CDC	NHLBI	2017
CDC Pathogen Genomic Centers of Excellence (PGCoE)	Research Initiative	CDC	NIAID	2022
CDC-NIH Lyme Disease Serum Sample Repository	Resource Development	CDC, OS	NIAID	2008
CDC/NIH Quarterly Check-ins	Other	CDC	NIMH, NIAID	2021
Central Brain Tumor Registry of the United States (CBTRUS)	Research Initiative	CDC		2021
Cervical screening guidelines	Resource Development	CDC, HRSA, FDA		2019
Chemical Hazards Emergency Medical Management (CHEMM) Working Group	Committee, Advisory Group, or Work Group	ASPR, CDC	NLM, NICHD	2010
Chronic Kidney Disease Surveillance System	Health Survey	CDC	NIDDK	2006
Circulating Estrogens, Androgens, and Progestogens and Risk of Breast Cancer in the PLCO Cohort	Research Initiative	CDC		2018
Clinical and Translational Serology Task Force (CTTF)	Resource Development	CDC, FDA, ASPR	NIAID	2021
Clinical Genome Resource and Genetic Testing Reference Material Program Collaborative Project (ClinGen and GeT-RM Collaborative Project)	Resource Development	CDC		2021
Clinical Immunization Safety Assessment Network (CISA)	Committee, Advisory Group, or Work Group	CDC	NIAID, NHLBI	2021
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics	Committee, Advisory Group, or Work Group	CDC, FDA	NIAID	2009
Clinical Pharmacology Quality Assurance Program (CPQA)	Other	CDC	NIAID	2021
Clinical Trials of Biodefense Vaccines (Dengue)	Research Initiative	CDC	NIAID
Clinical Utilization Plan for Anthrax Medical Countermeasure Use in a Mass Casualty Event (CUPAC) Medical Countermeasures Workgroup	Committee, Advisory Group, or Work Group	CDC		2013
Clinical Vocabulary and Standards Development for Meaningful Use of Electronic Medical Records	Resource Development	CDC, CMS, FDA, ONC	NLM	2008
Collaborative Acute Toxicity Modeling Suite (CATMoS)	Committee, Advisory Group, or Work Group	ATSDR, CDC	NCATS	2018
Collaborative on Healthy Parenting in Primary Care	Public Education Campaign	CDC, HRSA, SAMHSA	NICHD
Combating Antibiotic Resistant Bacteria (CARB)	Resource Development	CDC, FDA	NHGRI, NIAID	2015
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) Joint Oversight Committee (CARBx-JOC)	Committee, Advisory Group, or Work Group	BARDA, CDC	NIAID	2016
Combined Exposures and Mixtures Research Program	Research Initiative	ATSDR, CDC, FDA, OASH	NIEHS
Commissioned Corps of the U.S. Public Health Service (USPHS) Oral Health Coordinating Committee (OHCC)	Committee, Advisory Group, or Work Group	ACF, ACL, AHRQ, CDC, CMS, FDA, OASH, IHS, SAMHSA		1990
Community Guide Cardiovascular Coordination Team	Committee, Advisory Group, or Work Group	CDC	NHLBI	2013
Community Preventive Services Task Force (CPSTF)	Committee, Advisory Group, or Work Group	CDC, CMS, AHRQ, OASH, HRSA, IHS, SAMHSA	OD/ DPCPSI	1996
Congenital Heart Public Health Consortium	Resource Development	AHRQ, CDC	NHLBI	2008
Consumer Product Chemical Exposures in Pregnancy and Their Cumulative Impact on Disorders of Fetal Growth	Research Initiative	CDC		2020
COPD National Action Plan	Meeting/ Workshop	AHRQ, CDC, CMS, HRSA, IHS	NCI, NHLBI, NIA, NIEHS, NINR	2017
Country Work in Cancer Research and Cancer Control Planning Strengthening – Kenya	Research Initiative	CDC	FIC, NIAID	2013
Covid Serology Research and Results Tracker (SeroHub)	Resource Development	CDC	NIAID	2020
COVID-19 and Influenza Scenario Modeling Hubs (SMH)	Research Initiative	CDC	NIGMS	2020
COVID-19 Health and Safety Briefs	Training Initiative	CDC		2021
COVID-19 Therapeutics Interagency Working Group	Committee, Advisory Group, or Work Group	FDA, CDC	NIAID	2020

Funding levels reported in the Fiscal Year 2022 Intra-Agency Collaborations Reporting System (CRS) may not be consistent with funding levels reported under the Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) at the NIH Office of Budget Website at http://report.nih.gov/categorical_spending.aspx. The current process, implemented in 2008 through the Research, Condition, and Disease Categorization (RCDC) system, uses sophisticated text data mining (categorizing and clustering using words and multiword phrases) in conjunction with NIH-wide definitions used to match projects to categories. RCDC use of data mining improves consistency and eliminates the wide variability in defining the research categories reported. The definitions are a list of terms and concepts selected by NIH scientific experts to define a research category. The research category levels represent the NIH’s best estimates based on the category definitions.